Flavia Foca

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications

DLL3 expression in neuroendocrine carcinomas: a comparative analysis across tumor origins.

DLL3 expression in neuroendocrine carcinomas: a comparative analysis across tumor origins.

Journal: Frontiers in endocrinology
Published: April 24, 2026

Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis.

Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis.

Journal: Breast (Edinburgh, Scotland)
Published: April 24, 2026

Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.

Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.

Journal: Biomedicines
Published: December 23, 2025

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.

Journal: Frontiers in immunology
Published: November 28, 2025

Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial.

Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial.

Journal: Frontiers in oncology
Published: October 08, 2025

Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Journal: European journal of nuclear medicine and molecular imaging
Published: July 14, 2025

Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.

Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.

Journal: Neuroendocrinology
Published: June 12, 2024

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Journal: Cancers
Published: April 15, 2024

First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).

First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).

Journal: Frontiers in immunology
Published: March 21, 2024

Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes.

Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes.

Journal: Journal of pain and symptom management
Published: February 26, 2024

A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas.

A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 08, 2024

Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients.

Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients.

Journal: Cancers
Published: December 21, 2023
Showing 1-12 of 80

Last Updated: 09/26/2026